Viewing nowCombinationTelmidipin Al Tablet 40/5/10 mg (Telmisartan, Amlodipine, Rosuvastatin)
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 201803759 · Approved 2018.09.18 · Insurance code 657806290
Treatment of hypertension, improvement of dyslipidemia, slowing of atherosclerosis progression, and reduction of cardiovascular disease risk
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure even with the monotherapy of Telmisartan and Amlodipine combination. Additionally, Rosuvastatin acts as an adjunct to dietary therapy for patients with hypercholesterolemia and mixed hyperlipidemia, lowering blood cholesterol levels and delaying the progression of atherosclerosis. It helps reduce the risks of stroke, myocardial infarction, and arterial revascularization, especially for high-risk patients with elevated high-sensitivity C-reactive protein levels. By managing both blood pressure and cholesterol, it effectively improves the risk of cardiovascular diseases.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is administered to adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients receiving concomitant treatment with a telmisartan/amlodipine combination and rosuvastatin as a single agent, switching to this medicine (a combination product with the same amounts of each active ingredient) may be considered for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, treatment should be started at a low dose and the dose increased gradually, because amlodipine clearance is reduced. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response. The dose may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended starting dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients of this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, the Cmax of rosuvastatin increased approximately 2.4-fold and the AUC increased approximately 1.3-fold in the presence of telmisartan/amlodipine. Therefore, when administering this medicine, the potential risk resulting from the increase in rosuvastatin Cmax should be assessed, and patients should be monitored closely.
This medication can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to this medication or similar drugs or those with certain diseases. Patients with severe liver or kidney impairment, certain heart diseases, and muscle-related diseases should take this medication carefully and undergo regular check-ups as directed by their physician. If muscle pain, muscle weakness, or any other muscle-related symptoms occur during treatment with this drug, consult a doctor immediately and blood tests should be performed as necessary to check for muscle damage. Patients with excessively low blood pressure, hyperkalemia, elderly patients, gastrointestinal diseases, etc., should use caution when taking this medication, and dosage adjustments or additional tests may be necessary depending on symptoms. This medication may interact with other drugs, so if you are taking other medications, be sure to inform your doctor or pharmacist, particularly when used in conjunction with specific antibiotics, immunosuppressants, anticoagulants, etc. Women who may become pregnant should use appropriate contraception and it is recommended not to use this medication while breastfeeding. Use in children or adolescents under the age of 18 is not recommended as safety and efficacy have not been sufficiently established. In case of overdose, symptoms such as hypotension, dizziness, and renal dysfunction may occur, so immediate medical attention is necessary, and since there is no specific antidote, treatment will be supportive based on the symptoms. Store in a place out of reach of children and do not transfer to another container.
Viral upper respiratory tract infection, dyspnea, rectal bleeding, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, dysuria, rhinitis, pharyngeal discomfort, lung disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory infection, low back pain, sinusitis, diarrhea, pharyngitis, influenza-like symptoms, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, cough, hypertension, chest pain, nausea, palpitations, dependent edema, angina pectoris, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, sensory disturbances, involuntary muscle contractions, erectile dysfunction, increased sweating, flushing, allergies, fever, leg pain, malaise, palpitations, vascular edema, vascular edema, erythema multiforme, pruritus, rash, erythematous rash, papular rash, frequent urination, urinary disorders, nocturnal enuresis, dry mouth, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, thrombocytopenia, jaundice, hepatitis, transaminase increase, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory impairment, forgetfulness, amnesia, memory disorder, confusion, hypotension, tachycardia, bradycardia, acute renal failure, hypoglycemia, syncope, muscle cramps, thrombocytopenia, increased uric acid, vasculitis, peripheral neuropathy, tremors, appetite loss, dysphagia, flatulence, vomiting, gingival hyperplasia, burning sensation, malaise, pain, rigidity, weight gain, weight loss, vascular edema, skin depigmentation, dry skin, hair loss, dermatitis, muscle weakness, single contraction, coordination disorder, hypertonia, apathy, anxiety, amnesia, gastritis, increased appetite, loose stools, rhinitis, urinary disorders, polyuria, abnormal olfaction, taste disorder, abnormal eye control, xerophthalmia, gynecomastia, jaundice, elevated liver enzyme levels, leukopenia, confusion, exfoliative dermatitis, Stevens-Johnson syndrome, photosensitivity reaction, toxic epidermal necrolysis, vascular edema, headache, dizziness, weakness, cough, nausea, fatigue, weakness, edema, facial edema, lower limb edema, vascular edema, pruritus, hypersensitivity reaction, increased sweating, erythema, chest pain, atrial fibrillation, congestive heart failure, myocardial infarction, increased blood pressure, worsening hypertension, hypotension, hyperkalemia, dyspepsia, diarrhea, urinary tract infection, erectile dysfunction, low back pain, abdominal pain, muscle cramps, myalgia, bradycardia, eosinophilia, thrombocytopenia, increased uric acid, liver dysfunction, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a tightly sealed container that blocks light. It is best to store it at room temperature between 1 to 30 degrees Celsius.
Pink oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.